BRIEF-Janssen receives two FDA approvals for SIMPONI ARIA for treatment of active psoriatic arthritis

* Janssen receives two U.S. FDA approvals for SIMPONI ARIA® (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.